Neurocognitive disorders (NCD) are underdiagnosed in primary care, mainly because of the misunderstanding of benefits associated with timely diagnosis.
Objective:
The aim of this study was to explore the benefits and risks of diagnosis in a population of general practitioners (GPs), specialized physicians (SPs), other healthcare professionals (HPs), and informal caregivers (ICs).
Methods:
A questionnaire was submitted to GPs, SPs, HPs. and ICs. It aimed at evaluating benefits and risks related to NCD diagnosis associated with four prototypical clinical cases at different stages: isolated cognitive complaint/mild NCD, major NCD at mild/moderate stage, moderate stage with behavioral and psychotic symptoms, and severe stage. The concepts of early, timely, and personalized diagnosis were evaluated.
Results:
A total of 719 completed surveys were collected from 183 GPs, 176 SPs, 281 HPs, and 79 ICs. More than 90% of the participants considered initiating a diagnosis as relevant except at the severe stage. Benefits were superior to risks for all groups and all four cases alike (p < 0.001). Benefits were lower according to GPs and higher for SPs than the other groups at the first two stages (p < 0.001). At the moderate stage, there were few differences between groups. At the severe stage, GPs and SPs claimed it was less relevant to carry out a diagnosis than the other groups (p < 0.001). Risks were higher for ICs and lower for SPs (p < 0.001). The best diagnosis concept was the personalized diagnosis.
Conclusion:
Benefits appeared more relevant than risks with differences according to the stage of the disease and type of respondents.
World Health Organization. Dementia: A public health priority. World Health Organization source. 2012.
2.
World Health Organization. The Global Impact of Dementia. World Health Organization. 2015.
3.
WinbladB, AmouyelP, AndrieuS, BallardC, BrayneC, BrodatyH, Cedazo-MinguezA, DuboisB, EdvardssonD, FeldmanH, FratiglioniL, FrisoniGB, GauthierS, GeorgesJ, GraffC, IqbalK, JessenF, JohanssonG, JönssonL, KivipeltoM, KnappM, MangialascheF, MelisR, NordbergA, RikkertMO, QiuC, SakmarTP, ScheltensP, SchneiderLS, SperlingR, TjernbergLO, WaldemarG, WimoA, ZetterbergH (2016) Defeating Alzheimer’s disease and other dementias: A priority for European science and society. Lancet Neurol15, 455–532.
4.
HofmanA, BrusselleGGO, MuradSD, van DuijnCM, FrancoOH, GoedegebureA, IkramMA, KlaverCCW, NijstenTEC, PeetersRP, StrickerBHC, TiemeierHW, UitterlindenAG, VernooijMW (2015) The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol30, 661–708.
5.
SatizabalCL, BeiserAS, ChourakiV, ChêneG, DufouilC, SeshadriS (2016) Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med374, 523–532.
6.
Plan Maladies Neuro-Dégénératives - Plan_maladies_neuro_degeneratives_def.pdf.
7.
ConnollyA, GaehlE, MartinH, MorrisJ, PurandareN (2011) Underdiagnosis of dementia in primary care: Variations in the observed prevalence and comparisons to the expected prevalence. Aging Ment. Health15, 978–984.
DartiguesJ-F, HelmerC (2009) Comment expliquer le retard au diagnostic de maladie d’Alzheimer en France?Gerontol Soc32, 183–193.
10.
PradierC, SakarovitchC, Le DuffF, LayeseR, MetelkinaA, AnthonyS, TifrateneK, RobertP (2014) The Mini Mental State Examination at the time of Alzheimer’s disease and related disorders diagnosis, according to age, education, gender and place of residence: A cross-sectional study among the French National Alzheimer Database. PLoS One9, e103630.
11.
DuboisB, PadovaniA, ScheltensP, RossiA, Dell’AgnelloG (2016) Timely diagnosis for Alzheimer’s disease: A literature review on benefits and challenges. J Alzheimers Dis49, 617–631.
12.
CarpenterB, DaveJ (2004) Disclosing a dementia diagnosis: A review of opinion and practice, and a proposed research agenda. Gerontologist44, 149–158.
13.
OuimetM-A, DendukuriN, DionD, BeizileE, ElieM (2004) Disclosure of Alzheimer’s disease. Senior citizens’ opinions. Can Fam Physician50, 1671–1677.
14.
CornettPF, HallJR (2008) Issues in disclosing a diagnosis of dementia. Arch Clin Neuropsychol23, 251–256.
15.
HolzerFJ, AssalF, LaszloA, AnnoniJ-M (2012) Risk and benefits of disclosing a diagnosis of dementia. Rev Med Suisse8, 1130–1134.
16.
ConnellCM, BoiseL, StuckeyJC, HolmesSB, HudsonML (2004) Attitudes toward the diagnosis and disclosure of dementia among family caregivers and primary care physicians. Gerontologist44, 500–507.
17.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCR, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
18.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
RayhanRU, ZhengY, UddinE, TimbolC, AdewuyiO, BaraniukJN (2013) Administer and collect medical questionnaires with Google documents: A simple, safe, and free system. Appl Med Inform33, 12.
22.
BreiningA, LavallartB, PinS, LéonC, MouliasS, ArwidsonP, BeckF, BerrC, VernyM (2014) Perception of Alzheimer’s disease in the French population. J Nutr Health Aging18, 393–399.
23.
PrinsA, HemkeF, PolsJ, Moll van CharanteEP (2016) Diagnosing dementia in Dutch general practice: A qualitative study of GPs’ practices and views. Br J Gen Pract66, e416–e422.
24.
TangEYH, BirdiR, RobinsonL (2016) Attitudes to diagnosis and management in dementia care: Views of future general practitioners. Int Psychogeriatr30, 425–430.
25.
FoleyT, BoyleS, JenningsA, SmithsonWH (2017) “We’re certainly not in our comfort zone”: A qualitative study of GPs’ dementia-care educational needs. BMC Fam Pract18, 66.
26.
PetrazzuoliF, VinkerS, KoskelaTH, FreseT, BuonoN, SolerJK, AhrensbergJ, AsenovaR, Foguet BoreuQ, Ceyhun PekerG, CollinsC, HanževačkiM, HoffmannK, IftodeC, KurpasD, Le ResteJY, LichtwarckB, PetekD, PintoD, SchransD, StreitS, TangEYH, TatsioniA, TorzsaP, UnalanPC, van MarwijkH, ThulesiusH (2017) Exploring dementia management attitudes in primary care: A key informant survey to primary care physicians in 25 European countries. Int Psychogeriatr29, 1413–1423.
27.
LliffeS, ManthorpeJ (2004) The hazards of early recognition of dementia: A risk assessment. Aging Ment Health8, 99–105.
28.
AminzadehF, MolnarFJ, DalzielWB, AyotteD (2012) A review of barriers and enablers to diagnosis and management of persons with dementia in primary care. Can Geriatr J15, 85–94.
29.
MilneA (2010) Dementia screening and early diagnosis: The case for and against. Health Risk Soc12, 65–76.
30.
MattssonN, BraxD, ZetterbergH (2010) To know or not to know: Ethical issues related to early diagnosis of Alzheimer’s disease. Int J Alzheimers Dis2010, 841941.
31.
BunnF, GoodmanC, SwornK, RaitG, BrayneC, RobinsonL, McNeillyE, IliffeS (2012) Psychosocial factors that shape patient and carer experiences of dementia diagnosis and treatment: A systematic review of qualitative studies. PLoS Med9, e1001331.
32.
SelmèsJ, DerouesnéC (2004) On the disclosure of the diagnosis of Alzheimer’s disease. Psychol Neuropsychiatr Vieil2, 133–140.
33.
FiskJD, BeattieBL, DonnellyM, ByszewskiA, MolnarFJ (2007) Disclosure of the diagnosis of dementia. Alzheimers Dement3, 404–410.
34.
Krolak-SalmonP, LetrilliartL, CeccaldiM, AndrieuS, GuérinO, DuboisB, BrochetB, VandelP, JeandelC, Leperre-DesplanquesA, ClanetM, DruaisP-L (2018) Vers une stratégie nationale de diagnostic des troubles cognitifs. Appcommune du Collège de médecine générale et des spécialistes des troubles neurrocheocognitifs. Presse Med47, 75–83.
35.
GaboreauY, ImbertP, JacquetJ-P, PaumierF, CouturierP, GavazziG (2014) Factors affecting dementia screening by general practitioners in community-dwelling elderly populations: A large cross-sectional study in 2 areas of France. Alzheimer Dis Assoc Disord28, 58–64.
36.
SommeD, GautierA, PinS, CorvolA (2013) General practitioner’s clinical practices, difficulties and educational needs to manage Alzheimer’s disease in France: Analysis of national telephone-inquiry data. BMC Fam Pract14, 81.
37.
RobinsonL, VellasB, KnoxS, LinsK (2010) Clinical practice patterns of generalists and specialists in Alzheimer’s disease: What are the differences, and what difference do they makeJ Nutr Health Aging14, 545–552.
38.
RobinsonSM, CanavanM, O’KeeffeST (2014) Preferences of older people for early diagnosis and disclosure of Alzheimer’s disease (AD) before and after considering potential risks and benefits. Arch Gerontol Geriatr59, 607–612.
